Progress in Neuro-Psychopharmacology and Biological Psychiatry 2001-04-01

Simultaneous analysis of clozapine, clomipramine and their metabolites by reversed-phase liquid chromatography.

L Palego, L Dell'Osso, D Marazziti, L Biondi, N Sarno, A Ciapparelli, A Giromella, G Giannaccini, LucacchiniA, G B Cassano

Index: Prog. Neuropsychopharmacol. Biol. Psychiatry 25(3) , 519-33, (2001)

Full Text: HTML

Abstract

1. The authors present here a sensitive and rapid reversed-phase liquid chromatographic method which enables the simultaneous analysis in plasma of two different drugs and their metabolites: the atypical neuroleptic clozapine and the tricyclic antidepressant clomipramine. 2. Samples and the internal standard (dibenzepine) were extracted through automated solid-phase procedure, evaporated dryness and injected into the chromatograph. Mobile phase was a mixture of water and acetonitrile (63:37, v:v) containing TEMED and triethylamine. The total chromatographic time was of 14 min and analyte peaks were detected by means of an ultraviolet spectrophotometer preset at 254 nm. 3. Results revealed an assay sensitivity of 5 microg/L for clozapine or norclozapine and of 10 microg/L for clomipramine and desmethylclomipramine. Recoveries for these drugs and their metabolites were more than 60% and their coefficient of variation (within day and day-to-day) ranged from 1.3 % to 2.5 %. In spiked plasma, within day and day-to-day coefficients of variability (CV) were less than 5%. The simultaneous evaluation of these two drugs with adequate sensitivity and precision makes it particularly useful for therapeutic drug monitoring during mono- or polypharmacotherapy.


Related Compounds

  • Didemethylclomipra...
  • N-Desmethyl Clomi...

Related Articles:

Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine.

2000-09-01

[Eur. Neuropsychopharmacol. 10(5) , 401-5, (2000)]

Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data.

1993-12-01

[J. Affect. Disord. 29(4) , 267-79, (1993)]

Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration.

2000-01-01

[Am. J. Vet. Res. 61(1) , 80-5, (2000)]

Simultaneous plasma level analysis of clomipramine, N-desmethylclomipramine, and fluvoxamine by reversed-phase liquid chromatography.

2000-04-01

[Ther. Drug Monit. 22(2) , 190-4, (2000)]

Increased antipanic efficacy in combined treatment with clomipramine and dixyrazine.

1994-04-01

[Acta Psychiatr. Scand. 89(4) , 230-4, (1994)]

More Articles...